KW-2478

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameKW-2478
Drug Alias NameKW-2478
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsMultiple MyelomaLymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPhilippinesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kirin Pharma IncKyowa Kirin Co LtdKyowa Hakko Kirin Uk Ltd
Active IndicationsN/A
Inactive IndicationsMultiple MyelomaLymphoma, B-CellLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A